Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD Helen J. McBrideAshley Frazer-AbelJennifer Liu Original Article Open access 10 October 2023 Pages: 3299 - 3309
Macrophage depletion using clodronate liposomes reveals latent dysfunction of the hematopoietic microenvironment associated with persistently imbalanced M1/M2 macrophage polarization in a mouse model of hemophagocytic lymphohistiocytosis Takashi KoikeKatsuhiro MiuraShin Aizawa Original Article 01 September 2023 Pages: 3311 - 3323
An analysis of sintilimab combined with ruxolitinib as compassionate therapy for 12 adults with EBV-associated hemophagocytic lymphohistiocytosis Ying XuWenting LiXiaoping Huang Original Article 03 October 2023 Pages: 3325 - 3333
The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease Jia‑wen DaiHe LinXin-xin Cao Original Article 03 November 2023 Pages: 3335 - 3343
E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia Yanfeng LiuPeng ChenXiaoping Chen Original Article 04 September 2023 Pages: 3345 - 3355
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia Huibo LiJinxiao HouShengjin Fan Original Article 19 September 2023 Pages: 3357 - 3367
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study Guangyang WengJingya HuangXin Du Original Article 18 September 2023 Pages: 3369 - 3381
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial Steffen KoschmiederSusanne IsfortHeike L. Pahl Original Article Open access 04 October 2023 Pages: 3383 - 3399
Higher expression of programmed cell death 4 (PDCD4) in acute myeloid leukemia is associated with better prognosis after chemotherapy Hongwei TangYing ChenKang Zhou Original Article 25 October 2023 Pages: 3401 - 3412
Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study Hurong LaiYansong TuJian Li Original Article Open access 01 November 2023 Pages: 3413 - 3426
A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia Rodrick BabakhanlouMarc-Elie NaderYesid Alvarado Original Article 15 September 2023 Pages: 3427 - 3430
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015 Kangkang LiuJingbo ShaoHui Jiang Original Article 08 August 2023 Pages: 3431 - 3444
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma Patricia JohanssonStefan AligAndreas Hüttmann Original Article Open access 11 August 2023 Pages: 3445 - 3455
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy Marcella VisentiniAndrea PicaAlessandro Pulsoni Original Article Open access 31 August 2023 Pages: 3457 - 3463
Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China Xiaosheng LiQianjie XuHaike Lei Original Article Open access 24 August 2023 Pages: 3465 - 3475
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma Osama Abd El Hameed EbidLobna R. Ezz El ArabMenha Swellam Original Article Open access 02 September 2023 Pages: 3477 - 3488
Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies Taku KikuchiNobuhiro TsukadaTadao Ishida Original Article 05 September 2023 Pages: 3489 - 3497
c-Myc inhibits LAPTM5 expression in B-cell lymphomas Yanqing ZhangXin ZhangDuonan Yu Original Article 15 September 2023 Pages: 3499 - 3513
The experience of diagnosis and treatment for TAFRO syndrome Xiaolong WuXudong ZhangMingzhi Zhang Original Article 15 September 2023 Pages: 3515 - 3520
Clinical and prognostic role of sarcopenia based on masticatory muscle index on MR images in patients with extranodal natural killer/T cell lymphoma, nasal type Tianzi XuYi LiYongchang Wei Original Article 13 September 2023 Pages: 3521 - 3532
Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group Ronakrit ThanhakunKitsada Wudhikarnon behalf of the Thai Lymphoma Study Group Original Article 18 September 2023 Pages: 3533 - 3541
Predictors of health-related quality of life of the patients treated for MM: the first study in the Palestinian healthcare system Ramzi ShawahnaRiad AmerMohmmad Zain-Aldain Original Article 06 October 2023 Pages: 3543 - 3554
The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis Shufen WangXiaoyan YueHaowen Xiao Original Article 28 September 2023 Pages: 3555 - 3566
Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors Junjie CaoAizhen LiPeipei Ye Original Article 29 September 2023 Pages: 3567 - 3573
IL-10 plus the EASIX score predict bleeding events after anti-CD19 CAR T-cell therapy Xindi WangChenggong LiYu Hu Original Article Open access 09 October 2023 Pages: 3575 - 3585
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use Flora KovacsovaFrantisek FolberJiri Mayer Original Article Open access 03 October 2023 Pages: 3587 - 3591
Epstein–Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation Jiajia HuJie ZhaoShanshan Li Original Article 13 October 2023 Pages: 3593 - 3601
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms Xinhui ZhengHongye GaoMingzhe Han Original Article 25 October 2023 Pages: 3603 - 3611
Validation of venous thromboembolism predictive model in hematologic malignancies Agnerys López SacerioMara Caridad Tejeda RamónAnna Falanga Original Article 02 October 2023 Pages: 3613 - 3620
Discovering a novel pathogenic CDAN1 variant using exome sequencing and bioinformatics analysis Ling-Hu CaiChuan-Chuan LiuLu-Feng Li Letter to the Editor 21 August 2023 Pages: 3621 - 3623
Ibrutinib plus rituximab and lenalidomide for primary intestinal diffuse large B-cell lymphoma relapsed after anti-CD19 CAR-T cell therapy: a case report Changyou LiXiyuan ZhangPeng Zhao Letter to the Editor 22 August 2023 Pages: 3625 - 3627
A case report of dyskeratosis congenita caused by a novel TERC mutation Weiru LiangLei YeFengkui Zhang Letter to the Editor 09 September 2023 Pages: 3629 - 3630
Clonal hematopoiesis with TET2 mutations spawning synchronous primary central nervous system lymphoma and myelodysplastic syndrome Hannes TreiberChristina GansterGerald G. Wulf Letter to the Editor Open access 13 September 2023 Pages: 3631 - 3633
Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key? Oliver KriegeAndreas KreftEva-Maria Wagner-Drouet Letter to the Editor Open access 23 September 2023 Pages: 3635 - 3637
Safe and successful teclistamab treatment in very elderly multiple myeloma (MM) patients: a case report and experience from a total of three octogenarians Martin Philipp DieterleGila Mostufi-Zadeh-HaghighiMonika Engelhardt Letter to the Editor Open access 15 September 2023 Pages: 3639 - 3641
Clonal myeloid disorders following CAR T-cell therapy Michael Andersen JrPoorva BindalRushad Patell Letter to the Editor 26 September 2023 Pages: 3643 - 3645
The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia Ozlem CandanDerya DemirtasTayfur Toptas Letter to the Editor 20 September 2023 Pages: 3647 - 3648
Multiple myeloma relapse as extramedullary plasmacytoma of the penis Henrique CoelhoMargarida BadiorMárcio Tavares Letter to the Editor 25 September 2023 Pages: 3649 - 3651